Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
2021
Targeted immunotherapy of solid cancers with chimeric antigen receptor (CAR) T cells and immunocytokines are attractive options in that they both rely on the specificity of tumor-targeted antibodie...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
80
References
3
Citations
NaN
KQI